D9652
Dialysis tubing cellulose membrane
avg. flat width 33 mm (1.3 in.)
Sinonimo/i:
Cellulose Dialysis Tubing, Cellulose Membrane, Dialysis Membrane
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
About This Item
Codice UNSPSC:
41123100
NACRES:
NB.22
Prodotti consigliati
Diametro medio
21 mm , when full
Larg.media se piatto
33 mm (1.3 in.)
Capacità
~110 mL/ft
Cerchi prodotti simili? Visita Guida al confronto tra prodotti
Descrizione generale
Typical molecular weight cut-off = 14,000.
Confezionamento
Supplied in rolls, dry
Qualità
May contain glycerin and sulfur compounds in more than trace amounts.
Nota sulla preparazione
Removal of glycerol included as a humectant can be accomplished by washing the tubing in running water for 3-4 hours. Removal of sulfur compounds can be accomplished by treating the tubing with a 0.3% (w/v) solution of sodium sulfide at 80°C for 1 minute. Wash with hot water (60°C) for 2 minutes, followed by acidification with a 0.2% (v/v) solution of sulfuric acid, then rinse with hot water to remove the acid. This tubing will retain most proteins of molecular weight 12,000 or greater.
Codice della classe di stoccaggio
13 - Non Combustible Solids
Classe di pericolosità dell'acqua (WGK)
WGK 3
Punto d’infiammabilità (°F)
Not applicable
Punto d’infiammabilità (°C)
Not applicable
Certificati d'analisi (COA)
Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
I clienti hanno visto anche
Fereshteh Abbasi et al.
International journal of biological macromolecules, 143, 492-500 (2019-12-13)
Developing the cheap but superior adsorbents is of importance for environmental applications. In this paper, the Taguchi experimental design was applied to establish the optimum condition for the removal of crystal violet (CV) dye using keratin nanoparticles obtained from human
Margarida Miranda et al.
International journal of pharmaceutics, 572, 118695-118695 (2019-09-20)
The EMA draft guideline on quality and equivalence of topical products and the FDA non-binding product specific guidances release has encouraged the establishment of a regulatory background for in vitro release testing (IVRT). Herein, a novel framework applicable to the
Ahmet Alper Öztürk et al.
Combinatorial chemistry & high throughput screening, 23(10), 1064-1079 (2020-03-27)
To prepare lamivudine (LAM)-loaded-nanoparticles (NPs) that can be used in lung cancer treatment. To change the antiviral indication of LAM to anticancer. The development of anticancer drugs is a difficult process. One approach to accelerate the availability of drugs is
Ana Paula Dos Santos Matos et al.
Drug delivery and translational research, 10(6), 1552-1570 (2020-07-18)
Leishmaniasis is a neglected infectious disease caused by protozoan parasites from Leishmania genus species, affecting millions of people, in several countries. The current available treatment for cutaneous leishmaniasis (CL) has presented many side effects. In this way, micro- and nanotechnology
Carla Vitorino et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 153, 106-120 (2020-06-12)
Depression is a life-threatening psychiatric disorder and a multifactorial global public health concern. Current pharmacological treatments present limited efficacy, and are associated with several harmful side effects and development of pharmacoresistance mechanisms. Developing more effective therapeutic options is therefore a
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.